TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Clinical trial NCT01194960 · TERMINATED
Trial details
- NCT number
- NCT01194960
- Sponsor
- Oxford BioMedica
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2013-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.